Clinical trial
Evaluation of HCC Response to Systemic Therapy With Quantitative MRI
NCT01871545 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of HCC Response to Systemic Therapy With Quantitative MRI
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- February 2, 2018
- Enrollment
- 84 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hcc, hepatocellular carcinoma